Sehajdev Singh Bhatia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sehajdev Singh Bhatia has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anshuman P. Malaviya
Rheumatology Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
1 shared publication - Asha Notarianni
General Surgery, Jersey General Hospital, Saint Helier, Jersey
1 shared publication Bowen Li
1 shared publicationCarlo Canepa
Stroke and Neurology, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK
1 shared publicationChaozong Liu
1 shared publicationChunlan Jing
1 shared publication
Latest Publications
- Open Access
- 8 August 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (8) , e259439
FGF23-secreting sinonasal tumour presenting with acute subdural haemorrhage and tumour-induced osteomalacia
A female in her 50s developed a headache, collapsed and was noted to have an acute atraumatic subdural haemorrhage (SDH) requiring surgical evacuation and intracranial pressure-directed therapy. Her background included recurrent epistaxis, severe generalised bone pain and multiple insufficiency fractures and an undifferentiated autoimmune connective tissue disease. Chronic hypophosphataemia, elevated alkaline phosphatase and raised fibroblast growth factor 23 (FGF23) were also noted. An MRI head and subsequent 68Ga CT/positron emission tomography scan demonstrated an intensely avid tumour in the right ethmoid sinus, extending intracranially. Phosphate was aggressively replaced, and alfacalcidol was initiated to circumvent the effects of FGF23 on her kidneys and bone minerals. The tumour was biopsied and then definitively resected via combined endonasal and craniotomy approaches, resulting in good clinical improvement. FGF23 titre and serum phosphate both normalised leaving the diagnosis of a phosphaturic mesenchymal tumour-secreting FGF23, leading to tumour-induced osteomalacia.
- 8 August 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (8) , e259439
Open AccessFGF23-secreting sinonasal tumour presenting with acute subdural haemorrhage and tumour-induced osteomalacia
A female in her 50s developed a headache, collapsed and was noted to have an acute atraumatic subdural haemorrhage (SDH) requiring surgical evacuation and intracranial pressure-directed therapy. Her background included recurrent epistaxis, severe generalised bone pain and multiple insufficiency fractures and an undifferentiated autoimmune connective tissue disease. Chronic hypophosphataemia, elevated alkaline phosphatase and raised fibroblast growth factor 23 (FGF23) were also noted. An MRI head and subsequent 68Ga CT/positron emission tomography scan demonstrated an intensely avid tumour in the right ethmoid sinus, extending intracranially. Phosphate was aggressively replaced, and alfacalcidol was initiated to circumvent the effects of FGF23 on her kidneys and bone minerals. The tumour was biopsied and then definitively resected via combined endonasal and craniotomy approaches, resulting in good clinical improvement. FGF23 titre and serum phosphate both normalised leaving the diagnosis of a phosphaturic mesenchymal tumour-secreting FGF23, leading to tumour-induced osteomalacia.
- Open Access
- 13 December 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (12) , e251784
Bickerstaff’s brainstem encephalitis mimicking herpetic encephalomyelitis in a liver transplant patient with anti-GQ1b antibodies
A woman in her late 70s with a history of liver transplant presented with ophthalmoplegia, ataxia, areflexia, positive Babinski’s sign and reduced consciousness. This followed an antecedent illness in the form of a herpes zoster infection. MRI of the brain/spinal cord, cerebrospinal fluid analysis with viral PCR and routine blood tests were normal, and tacrolimus neurotoxicity was ruled out. Serum anti-GQ1b antibodies were positive. A diagnosis of Bickerstaff’s brainstem encephalitis was made, forming part of the continuum that involves Miller-Fisher syndrome, entitled the ‘anti-GQ1b syndrome’. Complete recovery ensued without intravenous immunoglobulins or plasma exchange. The role of monitoring anti-ganglioside pattern change to predict or confirm disease recurrence and disease severity is further discussed.
- 13 December 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (12) , e251784
Open AccessBickerstaff’s brainstem encephalitis mimicking herpetic encephalomyelitis in a liver transplant patient with anti-GQ1b antibodies
A woman in her late 70s with a history of liver transplant presented with ophthalmoplegia, ataxia, areflexia, positive Babinski’s sign and reduced consciousness. This followed an antecedent illness in the form of a herpes zoster infection. MRI of the brain/spinal cord, cerebrospinal fluid analysis with viral PCR and routine blood tests were normal, and tacrolimus neurotoxicity was ruled out. Serum anti-GQ1b antibodies were positive. A diagnosis of Bickerstaff’s brainstem encephalitis was made, forming part of the continuum that involves Miller-Fisher syndrome, entitled the ‘anti-GQ1b syndrome’. Complete recovery ensued without intravenous immunoglobulins or plasma exchange. The role of monitoring anti-ganglioside pattern change to predict or confirm disease recurrence and disease severity is further discussed.
- Open Access
- 15 April 2022
- Published by Elsevier in Polymer Testing
- Vol. 110
Bone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment
- 15 April 2022
- Published by Elsevier in Polymer Testing
- Vol. 110
Open AccessBone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment